Jonathan E. Kolitz

24.1k total citations · 3 hit papers
256 papers, 14.4k citations indexed

About

Jonathan E. Kolitz is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jonathan E. Kolitz has authored 256 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Hematology, 106 papers in Genetics and 84 papers in Molecular Biology. Recurrent topics in Jonathan E. Kolitz's work include Acute Myeloid Leukemia Research (136 papers), Chronic Lymphocytic Leukemia Research (82 papers) and Acute Lymphoblastic Leukemia research (57 papers). Jonathan E. Kolitz is often cited by papers focused on Acute Myeloid Leukemia Research (136 papers), Chronic Lymphocytic Leukemia Research (82 papers) and Acute Lymphoblastic Leukemia research (57 papers). Jonathan E. Kolitz collaborates with scholars based in United States, Italy and Germany. Jonathan E. Kolitz's co-authors include Richard A. Larson, R. Kanti, Steven L. Allen, Clara D. Bloomfield, Nicholas Chiorazzi, Bayard L. Powell, Krzysztof Mrózek, Guido Marcucci, Andrew J. Carroll and Rajendra N. Damle and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jonathan E. Kolitz

243 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia

1999 1.9k citations Rajendra N. Damle, Tarun Wasil et al. Blood profile →
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

2000 754 citations R. Kanti, Jonathan E. Kolitz et al. profile →
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

2010 548 citations Guido Marcucci, Kati Maharry et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jonathan E. Kolitz

Since Specialization

Citations

This map shows the geographic impact of Jonathan E. Kolitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Kolitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Kolitz more than expected).

Fields of papers citing papers by Jonathan E. Kolitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Kolitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Kolitz. The network helps show where Jonathan E. Kolitz may publish in the future.

Co-authorship network of co-authors of Jonathan E. Kolitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan E. Kolitz. A scholar is included among the top collaborators of Jonathan E. Kolitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan E. Kolitz. Jonathan E. Kolitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies 2025 ·Leukemia ·(unknown), Deedra Nicolet, (unknown), Daelynn R. Buelow, Shelley Orwick, Charles T. Gregory, (unknown), (unknown), Jonathan E. Kolitz, Bayard L. Powell, William Blum, Maria R. Baer, John C. Byrd, Wendy Stock, Geoffrey L. Uy, Krzysztof Mrózek, Ann‐Kathrin Eisfeld, Xiaolin Cheng, Sharyn D. Baker, James S. Blachly	1
2	Chronic lymphocytic leukemia often arises by a multiclonal selection process 2025 ·Haematologica ·Davide Bagnara, Andrea Nicola Mazzarello, (unknown), Stefano Vergani, Siddha Kasar, Stacey M. Fernandes, Gerardo Ferrer, Fabio Ghiotto, Jacqueline C. Barrientos, Jonathan E. Kolitz, R. Kanti, (unknown), Monica Colombo, Franco Fais, Jennifer R. Brown, Manlio Ferrarini, Nicholas Chiorazzi	0
3	BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism 2024 ·PubMed ·Hyunjoo Lee, Shabirul Haque, (unknown), Jonathan E. Kolitz, Steven L. Allen, R. Kanti, Nicholas Chiorazzi, Patricia K. A. Mongini	1
4	Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study 2023 ·Leukemia ·Krzysztof Mrózek, Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer, Alice S. Mims, Karilyn Larkin, Shelley Orwick, Christopher C. Oakes, Jonathan E. Kolitz, Bayard L. Powell, William Blum, Guido Marcucci, Maria R. Baer, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Ann‐Kathrin Eisfeld	31
5	Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study 2023 ·Blood Advances ·Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley Orwick, Daelynn R. Buelow, (unknown), Christopher C. Oakes, Jonathan E. Kolitz, Geoffrey L. Uy, Wendy Stock, Bayard L. Powell, Deedra Nicolet, Erin Hertlein, Krzysztof Mrózek, James S. Blachly, Ann‐Kathrin Eisfeld, Sharyn D. Baker, John C. Byrd	1
6	Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL 2021 ·Leukemia ·Gerardo Ferrer, (unknown), (unknown), Rukhsana Aslam, Florencia Palacios, Andrea Nicola Mazzarello, Stefano Vergani, Davide Bagnara, Shih‐Shih Chen, Sophia Yancopoulos, Aliki Xochelli, Xiao‐Jie Yan, Jan A. Burger, Jacqueline C. Barrientos, Jonathan E. Kolitz, Steven L. Allen, Κώστας Σταματόπουλος, R. Kanti, Barbara Sherry, Nicholas Chiorazzi	37
7	Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target 2021 ·Leukemia ·Florencia Palacios, Xiao‐Jie Yan, Gerardo Ferrer, Shih‐Shih Chen, Stefano Vergani, Xuejing Yang, Jeffrey R. Gardner, Jacqueline C. Barrientos, (unknown), Richard Burack, Jonathan E. Kolitz, Steven L. Allen, Michael G. Kharas, Omar Abdel‐Wahab, R. Kanti, Nicholas Chiorazzi	18
8	Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes 2019 ·International Journal of Surgical Pathology ·Mansoor Nasim, David J. Chalif, Alexis Demopoulos, Judith Brody, (unknown), Silvia Spitzer, Jonathan E. Kolitz, Xinmin Zhang	3
9	Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Dimitrios Papaioannou, Deedra Nicolet, Hatice Gülçin Özer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield	12
10	Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) 2018 ·Blood ·Marius Bill, Dario Veneziano, Jessica Kohlschmidt, Krzysztof Mrózek, Giovanni Nigita, (unknown), Deedra Nicolet, Dimitrios Papaioannou, Allison R. Walker, (unknown), Bayard L. Powell, Richard M. Stone, Geoffrey L. Uy, Jonathan E. Kolitz, Eunice S. Wang, Adrienne M. Dorrance, Carlo M. Croce, Ramiro Garzon, Clara D. Bloomfield	2
11	CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association 2017 ·Blood ·Yan Liu, Rosa Catera, Chao Gao, Xiao‐Jie Yan, Steven L. Allen, Jonathan E. Kolitz, R. Kanti, Charles C. Chu, Ten Feizi, Κώστας Σταματόπουλος, Nicholas Chiorazzi	1
12	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Alice S. Mims, Christopher J. Walker, James S. Blachly, Deedra Nicolet, Shelley Orwick, (unknown), Andrew J. Carroll, Bayard L. Powell, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield	0
13	Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies 2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, James S. Blachly, Christopher J. Walker, Deedra Nicolet, Shelley Orwick, Andrew J. Carroll, Richard M. Stone, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield	0
14	A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease 2011 ·Blood ·Davide Bagnara, Matthew Kaufman, Carlo Calissano, Sonia Marsilio, Piers Patten, Rita Simone, (unknown), Xiao‐Jie Yan, Steven L. Allen, Jonathan E. Kolitz, Sivasubramanian Baskar, Christoph Rader, Håkan Mellstedt, Hodjattallah Rabbani, Annette Lee, Peter K. Gregersen, R. Kanti, Nicholas Chiorazzi	145
15	Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells 2011 ·Molecular Medicine ·Carlo Calissano, Rajendra N. Damle, Sonia Marsilio, Xiao‐Jie Yan, Sophia Yancopoulos, Gregory M. Hayes, Claire Emson, Elizabeth J. Murphy, Marc K. Hellerstein, Cristina Sison, Matthew Kaufman, Jonathan E. Kolitz, Steven L. Allen, R. Kanti, (unknown), Igor Dozmorov, Sergio Roa, Matthew D. Scharff, Wentian Li, Nicholas Chiorazzi	129
16	Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance 2011 ·Haematologica ·Preetesh Jain, (unknown), (unknown), Percy Chiu, (unknown), Rajendra N. Damle, (unknown), Filiz Şen, Lynne V. Abruzzo, Jan A. Burger, Andreas Rosenwald, Steven L. Allen, Jonathan E. Kolitz, Michael R. Kanost, Nicholas Chiorazzi, Barbara Sherry	63
17	Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study 2009 ·Journal of Clinical Oncology ·Heiko Becker, Guido Marcucci, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Dean Margeson, Susan P. Whitman, Yue-Zhong Wu, Sebastian Schwind, Peter Paschka, Bayard L. Powell, Thomas H. Carter, Jonathan E. Kolitz, Meir Wetzler, Andrew J. Carroll, Maria R. Baer, Michael A. Caligiuri, Richard A. Larson, Clara D. Bloomfield	241
18	Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study 2008 ·Journal of Clinical Oncology ·Guido Marcucci, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Tamara Vukosavljevic, Peter Paschka, Susan P. Whitman, Christian Langer, Claudia D. Baldus, Chang‐Gong Liu, Amy S. Ruppert, Bayard L. Powell, Andrew J. Carroll, Michael A. Caligiuri, Jonathan E. Kolitz, Richard A. Larson, Clara D. Bloomfield	224
19	In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells 2005 ·Journal of Clinical Investigation ·Bradley T. Messmer, Davorka Messmer, Steven L. Allen, Jonathan E. Kolitz, (unknown), Denise Cesar, Elizabeth J. Murphy, Prasad Koduru, Manlio Ferrarini, Simona Zupo, Giovanna Cutrona, Rajendra N. Damle, Tarun Wasil, R. Kanti, Marc K. Hellerstein, Nicholas Chiorazzi	21
20	Pharmacokinetics of recombinant interleukin 2 in humans. 1990 ·PubMed ·Michael Konrad, George P. Hemstreet, Evan M. Hersh, Peter W. A. Mansell, Roland Mertelsmann, Jonathan E. Kolitz, Edward C. Bradley	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact